1 / 5

Europe Influenza Vaccines Market Forecast & Analysis to 2021

The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide.<br><br>Complete report available at: http://www.marketreportsonline.com/545525.html.

tim54
Download Presentation

Europe Influenza Vaccines Market Forecast & Analysis to 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 Order this report by calling +1 888 391 5441 or Send an email to sales@marketreportsonline.com with your contact details and questions if any. • Published: December 2016 • Pages: 110 • Price: US$ 1050 (Single User License)

  2. Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market. In the European influenza vaccines market, Germany accounts for majority of the market share. Italy is the second leading market for influenza vaccines in 2015. United Kingdom and France are the third and fourth leading market for influenza vaccines with XX% and XX% market share in 2015. Spain accounted for XX% share of the European influenza vaccines market in 2015. Netherlands, Ireland, Denmark, Luxembourg and Sweden are the other emerging market for influenza vaccines market. In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market. This research report titled "Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 110 Page report contains 57 Figures and 6 Tables to present a clear picture of the influenza vaccines market.

  3. Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 • The Influenza Vaccines Market have been analyzed from 5 viewpoints: • Europe Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021) • Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021) • Influenza Vaccines Brand Sales and Forecast to 2021 • Influenza Vaccines Market - Major Deals • Influenza Vaccines Market - Driving Factors and Challenges • Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution: Germany, France, Italy, Spain, United Kingdom, Netherlands, Ireland, Denmark, Luxembourg & Sweden • Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed • Fluarix/FluLaval • Fluzone • Fluvirin/Flucelvax • Influvac • Afluria/Fluvax • FluMist/Fluenz • Flublok • Purchase copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=545525.

  4. Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 • Major Points from Table of Contents: • 1. Executive Summary • 2. Europe - Influenza Vaccines Market Analysis and Forecast (2011 - 2020) 3. Europe - Influenza Vaccines Market Share Analysis and Forecast (2011 - 2021) • 4. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021) • 5. Influenza Vaccines Brand Sales and Forecast6. Influenza Vaccines Market - Major Deals7. Influenza Vaccines Market - Driving Factors8. Influenza Vaccines Market – Challenges • Other Related Reports on Influenza Vaccine Market: • Asia and Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 : The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. View Full Report at http://www.marketreportsonline.com/545526.html . • For Fax Order Request Form Click Here

  5. Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021 About Us: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Contact Us: RiteshTiwari 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India Tel: + 1 888 391 5441 E-mail: sales@marketreportsonline.com http://www.marketreportsonline.com/

More Related